Lord, Abbett & Co. LLC Bio Rad Laboratories, Inc. Transaction History

Lord, Abbett & Co. LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$708.84 - $794.68 $8.54 Million - $9.57 Million	-12,045 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$657.71 - $825.77 $2.98 Million - $3.74 Million	-4,524 Reduced 27.3%	12,045 $8.99 Million
Q2 2021 Aug 11, 2021	SELL	$576.64 - $649.04 $27,102 - $30,504	-47 Reduced 0.28%	16,569 $10.7 Million
Q1 2021 May 11, 2021	BUY	$547.01 - $662.35 $1.51 Million - $1.83 Million	2,760 Added 19.92%	16,616 $9.49 Million
Q4 2020 Feb 09, 2021	SELL	$510.68 - $643.45 $88,858 - $111,960	-174 Reduced 1.24%	13,856 $8.08 Million
Q3 2020 Nov 12, 2020	SELL	$454.43 - $535.6 $73,617 - $86,767	-162 Reduced 1.14%	14,030 $7.23 Million
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $101,800 - $149,890	304 Added 2.19%	14,192 $6.41 Million
Q1 2020 May 14, 2020	BUY	$320.01 - $409.07 $4.44 Million - $5.68 Million	13,888 New	13,888 $4.87 Million
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $13.3 Million - $15.6 Million	-56,900 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$216.94 - $271.3 $12.3 Million - $15.4 Million	56,900	56,900 $13.6 Million

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.15B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.